Ardsley Advisory Partners LP Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Ardsley Advisory Partners LP

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$98.85 - $138.91 $9.9 Million - $13.9 Million	-100,150 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$65.78 - $105.02 $2.33 Million - $3.72 Million	-35,400 Reduced 26.12%	100,150 $9.72 Million
Q1 2021 May 17, 2021	SELL	$64.07 - $91.75 $2.66 Million - $3.8 Million	-41,450 Reduced 23.42%	135,550 $9.27 Million
Q4 2020 Feb 16, 2021	SELL	$65.07 - $98.24 $5.21 Million - $7.86 Million	-80,000 Reduced 31.13%	177,000 $15.2 Million
Q3 2020 Nov 13, 2020	SELL	$59.04 - $77.95 $2.65 Million - $3.5 Million	-44,900 Reduced 14.87%	257,000 $16.7 Million
Q2 2020 Aug 14, 2020	SELL	$29.01 - $74.23 $2.01 Million - $5.15 Million	-69,350 Reduced 18.68%	301,900 $22.1 Million
Q1 2020 May 15, 2020	SELL	$27.51 - $57.29 $3.94 Million - $8.21 Million	-143,250 Reduced 27.84%	371,250 $12.6 Million
Q4 2019 Feb 14, 2020	SELL	$40.86 - $57.65 $6.13 Million - $8.64 Million	-149,950 Reduced 22.57%	514,500 $28 Million
Q3 2019 Nov 14, 2019	BUY	$37.38 - $49.47 $15.1 Million - $20 Million	403,950 Added 155.07%	664,450 $27.7 Million
Q2 2019 Aug 13, 2019	BUY	$39.79 - $67.01 $9.97 Million - $16.8 Million	250,500 Added 2505.0%	260,500 $11.4 Million
Q1 2019 May 15, 2019	BUY	$34.52 - $53.29 $345,200 - $532,900	10,000 New	10,000 $515,000
Q3 2018 Nov 14, 2018	SELL	$32.79 - $43.0 $327,900 - $430,000	-10,000 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$23.62 - $42.29 $236,200 - $422,900	10,000 New	10,000 $395,000

792K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.18B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of Ardsley Advisory Partners LP, based on Form 13F filings with the SEC.

Stay updated on Ardsley Advisory Partners LP with notifications on news.